Introduction across the secondary and primary interface. Seamless care is about helping patients move across the divide between primary and secondary healthcare sectors Methods without experiencing a gap in the standard of their health
The study was approved by the Ethical and Research management. Pharmaceutical care is a philosophy of directing Committee at the Royal Oldham Hospital. Elderly patients, pharmaceutical input to the needs of the individual patient aged 65 years or over, who were to be discharged to their with the aim of improving the patient's quality of own homes and who were likely to experience difficulties life [1] . At present this is practised in hospitals through with their medication (according to clinical pharmacist clinical pharmacy services but these must be transferred assessment from a checklist, e.g. appropriate use, understandto/implemented in the community to prevent a waste of ing of their medicine, mental impairment or medical resources because of either unnecessary visits to the general problems) were referred for possible entry to the study. practitioner or readmission to hospital.
Patients unable to read or open containers were excluded. Historically, there has been little formal contact between From the referrals received, patients were randomly selected hospital and community pharmacists about individual and asked to participate. Those giving written informed patients. The need for such links was emphasised with the consent were randomly assigned to a study or control group. implementation of the Community Care Act [2] . In 1992 a
Prior to discharge patients in the control and study groups policy statement on the pharmaceutical aspects of community received the usual pharmaceutical care provided by the care recommended that, prior to the discharge of patients Royal Oldham Hospital. They were given a medicine record with identified needs, hospital pharmacists should establish card [4] containing a summary of when to take their links with their community colleagues [3] . The document medicines together with a copy (coloured blue) of their also advocated the development and use of patient-held discharge prescription which contained written instructions information relevant to their in-patient treatment and to give the form to their doctor before they ran out of their discharge. This study has been carried out to evaluate how discharge medicines. Study group patients were verbally counselled by one of been prescribed, when to take their medicines, the correct use of their medication, side effects (and what to do if they Figure 1 shows that, in their own homes, study patients were coping with their medicines better than the control occur), the importance of compliance (and what to do if a dose is missed) and how to arrange a new supply. These patients. Statistical analysis (Chi-square) demonstrated significantly better (P<0.01) compliance levels and significantly were included in a written pharmaceutical care plan and given to the patient with instructions to show these plans less (P<0.01) counselling required to the study group. There was no difference in the altered medication between to their doctor and pharmacist. The patients in this group were also given details of a telephone helpline to contact the two groups. On discharge, two patients in each group had been issued with Medidos compliance aids. A further should they require help or advice during the first 7 days after discharge. A log-book to record the telephone calls six study group patients and 12 control group patients were issued with Medidos compliance aids following a contact and advice given was kept. For all patients the standard discharge letter from the hospital to the general practitioner with the patient's general practitioner during the domiciliary visit. In-patient assessment by the ward clinical pharmacist was sent as normal.
On discharge all patients were given sufficient medication, had revealed that eight study and 10 control patients could not manage CRCs on their medicine bottles. During the in bottles with non child resistant closures (CRCs), to last for 7 days and informed that they would receive a home visit it was found that three (of these eight) study and three (of these 10) control patients had been supplied CRCs with visit, by one of the study pharmacists, 7 to 10 days after discharge. Each patient was visited by a different project their first prescription supply. Two of these patients in each of the groups (four in total) were managing to take their pharmacist who counselled them prior to discharge. Visitors were unaware to which group each patient belonged.
medication by leaving the CRCs off the bottle while the others had tipped their medication into old containers which During this visit an assessment was made on how they were taking/using their medication. Their level of compliance did not have CRCs. One patient also had difficulty pressing tablets out of foil. was assessed by direct questions on which medicines they were currently taking/using and from which container, Contact was made with each general practitioner responsible for the healthcare of the 31 (14 study and 17 control) together with a tablet count and a record of their home medicine stocks. Their current medication was compared patients whose medication, during the domiciliary visit, was found to be different from that of discharge (altered with that of discharge and if there were any discrepancies then their general practitioner was contacted. For these medication category in Figure 1 ). The medication of all patients except one study patient was restored to that on interventions the patient's full clinical (including the reason for admission) and therapeutic history from the day prior to discharge. Table 1 shows the clinical panel's speculative assessment of the likely outcome if the 30 successful admission to the domiciliary visit, was made available to an independent clinical panel (one doctor and two clinical interventions had not been made. This panel also decided pharmacists) who decided what the outcome may have been without the intervention. These outcomes were classified as (A) of information use only, (B) restored the efficacy of the discharged medication, (C) prevented patient harm (i.e. side effects) and (D) as above but prevented a possible readmission to hospital.
Results
Thirty-four patients were recruited into the study group. In the period between discharge and the domiciliary visit (by the project pharmacist) six of these patients were withdrawn (one patient died, two were re-admitted to hospital, one went into residential care and two decided they did not want the visit). Of the 32 patients recruited into the control group seven patients were withdrawn prior to the domiciliary visit, (four died, one was readmitted and two went into 25 control group patients was 77.5 (7.3) and 77.6 (6.1) a incorrect use. years, respectively, and they were prescribed 5.2 (2.2) and 5.3 (2.2) medicines on discharge. Statistical analysis (Mann- peutic management had not been maintained after discharge.
Seamless pharmaceutical care
that for the one study patient whose general practitioner not suitable for the patient (e.g. inadequate diuretic therapy). Similarly many of the 'prevented harm' assessments were had deliberately altered the medication the change was of no clinical significance (information only). For each of the consistent with the admission data (e.g. phenytoin toxicity). The present system of written information passed between prevented hospital admissions the clinical panel decided that the average length of stay would have been 5 days. Thus at the primary and secondary healthcare sectors which relies heavily on the discharge letter from the patient's hospital local trust prices of £275 per night the cost of each admission, to the primary healthcare budget, would have consultant to their general practitioner does not ensure seamless care. Recently some trust hospitals have started to been £1375. use a Medication and Discharge Summary which is sent to the patient's general practitioner, nurse (if appropriate) and Discussion carer (if appropriate). Our study indicates that the patient's general practitioner should receive this in advance of the Failure to take medication as intended may be due to usual discharge letter from the consultant. A copy of this forgetting, a lack of understanding or deliberate nonform is also given to the patient to show to their doctor compliance. All patients were prescribed multiple drug and/or community pharmacist. Our study has shown that regimens and it has been identified that complex drug this back up channel cannot be relied upon. Medication to regimes are associated with non-compliance after hospital cover only 7 days may have been a major contributory discharge [5] . Of the patients in the control group 60% factor for the discrepancies in medication. This may be demonstrated faulty compliance during the domiciliary visit overcome if an appointment for the patient to see their compared with 18% in the study group. Although the general practitioner was made prior to discharge and method of assessment was mainly subjective it was the same sufficient medication to cover this period was dispensed. in both groups. Many elderly patients do have reduced
Eventually, interactive computerised technology should powers of recall during hospitalisation [5] and thus reinforceimprove the transfer of information but will require major ment of the counselling during a domiciliary visit is capital investment. Patients could receive their next necessary. Patients in the study group did not use the medication via an automatically arranged visit. Although telephone helpline although it was assessed that for 75.0%
the electronic transfer of information may help to ensure the domiciliary visit was important. This may be due to the supply of medication is seamless, all other aspects either the patient being unaware that there was a problem are the patient's responsibility and personal contact via a with their therapeutic management or the lack of familiarity pharmaceutical domiciliary visit may still be necessary. with a new (non-standard) service.
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